Jérôme Galon | |
|---|---|
| Born | February 6, 1967 |
| Alma mater | Jussieu University, Paris |
| Known for | Work on immunology and cancer |
| Awards | Louis-Jeantet Prize (2021), Award from Académie des sciences (2011), Award from Académie de médecine (2011), William B. Coley Award USA (2010) |
| Scientific career | |
| Fields | Immunology, cancer |
| Institutions | Pasteur Institute, Paris Curie Institute, Paris National Institute of Health (NIH), USA INSERM |
Jérôme Galon is a French biologist. He is a first class Research Director (DR1) at Institut National de la Santé et de la Recherche Médicale (INSERM).
Education
Galon received his Ph.D. degree (Doctorat ès science) with a specialty in immunology in 1996 and did postdoctoral work at the National Institute of Health (NIH), in Bethesda (USA) between 1997 and 2001. Since 2001, he has been working at the Cordeliers Research Center, where he has been the Director of the INSERM Laboratory Integrative Cancer Immunology since 2009.[1]
Scientific contributions
His work aims at a better understanding of the tumor microenvironment and the dynamics of the immune response in human tumors. His laboratory has identified and demonstrated the importance of the immune contexture against cancer. He defined the Immunoscore as a new method for routine clinical assessment of the prognosis of patients with cancer.
Awards and recognition
- NIH Excellence Research Award (1999)
- Prix Shaeverbeke from Fondation de France (2008)
- Prix Rose Lamarca from Fondation pour la recherche médicale (2008)
- William B. Coley Award of the Cancer Research Institute (2010)
- Prix Simone et Cino Del Duca from the French Academy of Sciences Académie des sciences (2011)
- Prix Gallet et Breton from the French Academy of Medicine Académie de médecine (2011)
- European Inventor Award (2019)
- Louis-Jeantet Prize (2021)
References
- Galon, Jérôme; Mlecnik, Bernhard; Bindea, Gabriela; Angell, Helen K; Berger, Anne; Lagorce, Christine; et al. (10 December 2013). "Towards the introduction of the 'Immunoscore' in the classification of malignant tumours". The Journal of Pathology. Wiley. 232 (2): 199–209. doi:10.1002/path.4287. ISSN 0022-3417. PMC 4255306. PMID 24122236.
- Bindea, Gabriela; Mlecnik, Bernhard; Tosolini, Marie; Kirilovsky, Amos; Waldner, Maximilian; Obenauf, Anna C.; Angell, Helen; Fredriksen, Tessa; Lafontaine, Lucie; Berger, Anne; Bruneval, Patrick; Fridman, Wolf Herman; Becker, Christoph; Pagès, Franck; Speicher, Michael R.; Trajanoski, Zlatko; Galon, Jérôme (2013). "Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer". Immunity. Elsevier BV. 39 (4): 782–795. doi:10.1016/j.immuni.2013.10.003. ISSN 1074-7613. PMID 24138885.
- Galon, Jérôme; Angell, Helen K.; Bedognetti, Davide; Marincola, Francesco M. (2013). "The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures". Immunity. Elsevier BV. 39 (1): 11–26. doi:10.1016/j.immuni.2013.07.008. ISSN 1074-7613. PMID 23890060.
External links
- Laboratory of Integrative Cancer Immunology homepage
- Official CV at Laboratory of Integrative Cancer Immunology